poisar

Stocks · News reference

Cepheid Receives FDA Clearance for Xpert Hemorrhagic Fever Panel

Fiscal.ai

Danaher subsidiary Cepheid has received U.S. FDA clearance for a new multiplex PCR test capable of detecting multiple viral hemorrhagic fever viruses from a single sample.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading